Department of Surgery, University Hospital, Ulm, Germany.
JAMA Surg. 2013 Feb;148(2):109-15. doi: 10.1001/2013.jamasurg.316.
To assess anxiety and depression symptoms, suicidal ideation, and health-related quality of life (HRQOL) in a large series of consecutive patients with primary hyperparathyroidism (pHPT) before and after parathyroidectomy.
This prospective multicenter study investigated preoperative and postoperative depression, anxiety, suicidal ideation, and HRQOL in patients with pHPT and compared these variables with a control group with nontoxic thyroid nodules.
The study included 194 patients with pHPT and 186 control subjects.
Depression was evaluated with the Hospital Anxiety and Depression Scale (HADS) and the Patient Health Questionnaire-9, which also assessed suicidal ideation. Anxiety was evaluated with the HADS. Health-related quality of life was measured with the 36-Item Short Form survey.
Parathyroidectomy achieved a 98% cure rate. Preoperatively, severe depression (HADS score ≥ 11) was seen in 20% of the pHPT group and 9% of the control group. The Patient Health Questionnaire-9 detected moderate to severe depression in 17% of the patients with pHPT and 7% of the control subjects. Patients with pHPT had higher HADS anxiety scores (mean, 7.7) than control subjects (P < .01) or the German normative sample (P < .001). Compared with control subjects, patients with pHPT had significantly lower 36-Item Short Form survey preoperative physical and mental health summary scores (42.7 vs 49.5 and 41.2 vs 46.8, respectively; P = .001 for both comparisons). At 12 months follow-up, depression and anxiety decreased significantly in patients with pHPT; the prevalence of suicidal ideation was more than halved from the baseline (10.7% vs 22%; P = .008). Both physical and mental health scores (45.7 and 47.7, respectively) improved in patients with pHPT (P < .001 each) but not in control subjects.
Depression, anxiety, and decreased HRQOL appear to be related to pHPT. Successful parathyroidectomy seems to reduce psychopathologic symptoms and improve HRQOL in this setting.
评估原发性甲状旁腺功能亢进症(pHPT)患者甲状旁腺切除术前和术后的焦虑、抑郁症状、自杀意念和健康相关生活质量(HRQOL)。
这项前瞻性多中心研究调查了 pHPT 患者术前和术后的抑郁、焦虑、自杀意念和 HRQOL,并将这些变量与非毒性甲状腺结节对照组进行了比较。
该研究纳入了 194 例 pHPT 患者和 186 例对照组患者。
采用医院焦虑抑郁量表(HADS)和患者健康问卷-9(同时评估自杀意念)评估抑郁;采用 HADS 评估焦虑;采用 36 项简短健康调查问卷评估 HRQOL。
甲状旁腺切除术的治愈率为 98%。术前,pHPT 组有 20%的患者出现严重抑郁(HADS 评分≥11),而对照组有 9%的患者出现严重抑郁。pHPT 组 17%的患者存在中重度抑郁,而对照组有 7%的患者存在中重度抑郁。与对照组相比,pHPT 组患者的 HADS 焦虑评分(平均 7.7)更高(P<0.01)或高于德国常模样本(P<0.001)。与对照组相比,pHPT 组患者术前 36 项简短健康调查问卷的生理和心理健康综合评分明显更低(分别为 42.7 对 49.5 和 41.2 对 46.8;两者均 P<0.001)。在 12 个月的随访中,pHPT 患者的抑郁和焦虑显著下降;自杀意念的发生率从基线时的 10.7%降至 5.2%(P=0.008)。pHPT 患者的生理和心理健康评分(分别为 45.7 和 47.7)均有所改善(两者均 P<0.001),但对照组患者无此改善。
抑郁、焦虑和 HRQOL 降低似乎与 pHPT 有关。甲状旁腺切除术成功似乎可减轻此类患者的精神病理症状并改善其 HRQOL。